Disclosure about Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2016


		September 30, 2016				December 31, 2015
		Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets:
	Mortgage loans receivable	$	498,993	$	525,400	$	635,492	$	663,501
	Other real estate loans receivable		131,027		132,999		184,000		185,693
	Available-for-sale equity investments		17,527		17,527		22,779		22,779
	Cash and cash equivalents		428,617		428,617		360,908		360,908
	Foreign currency forward contracts		130,454		130,454		129,520		129,520

Financial liabilities:
	Borrowings under unsecured credit facilities	$	1,350,000	$	1,350,000	$	835,000	$	835,000
	Senior unsecured notes		8,688,585		9,823,661		8,548,055		9,020,529
	Secured debt		3,317,933		3,509,792		3,509,142		3,678,564
	Foreign currency forward contracts		615		615		-		-

Redeemable OP unitholder interests		$	123,446	$	123,446	$	112,029	$	112,029


	Fair Value Measurements as of September 30, 2016
	Total		Level 1		Level 2		Level 3
Available-for-sale equity investments⁽¹⁾	$	17,527	$	17,527	$	-	$	-
Foreign currency forward contracts, net⁽²⁾		129,839		-		129,839		-
Redeemable OP unitholder interests		123,446		-		123,446		-
Totals	$	270,812	$	17,527	$	253,285	$	-

(1) Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date. During the year ended December 31, 2015, we recognized an other than temporary impairment charge of $35,648,000 on the Genesis Healthcare stock investment. Also, see Note 11 for details related to the gain on the derivative asset originally recognized.
(2) Please see Note 11 for additional information.